EWSR1 and neoplasm: Although a small study of a similar vaccine approach with tumor-lysate pulsed DCs later failed to produce tumor-specific T cell responses in patients with relapsed OS [49], a larger study demonstrated encouraging survival responses for EWS and RMS [77].